Literature DB >> 11306985

In vivo effects of apoptosis in asthma examined by a murine model.

K Ohta1, N Yamashita, M Tajima, T Miyasaka, R Kawashima, J Nakano, H Arioka, A Ishii, T Horiuchi, T Miyamoto.   

Abstract

BACKGROUND: One of the characteristic features of bronchial asthma is the accumulation of various inflammatory cells, predominantly eosinophils, at the subepithelial region beneath the basement membrane of the airway. Apoptosis is a form of physiological cell death, through which the cellular contents including biologically active substances are kept in the cell membrane and are removed without their harmful effects. So, attempts were made to clarify whether the induction of apoptosis is beneficial in asthma by using a murine model with ovalbumin (OA) as responsible allergen.
METHODS: A/J mice, which are genetically predisposed to be hyperresponsive to acetylcholine, were immunized with OA and alum, accompanied by OA inhalation for 2 weeks, during which some of the mice were also treated with either anti-Fas monoclonal antibody or sham control hamster IgG intranasally. Airway responsiveness to acetylcholine was then analyzed by measuring airway resistance with a body plethysmograph box. Apoptosis was assessed by propidium iodide and TUNEL staining.
RESULTS: Inhalation of OA increased both airway responsiveness to acetylcholine and the number of cells, mostly eosinophils, infiltrated into the airway. Administration of anti-Fas antibody induced apoptosis in the infiltrated eosinophils and abolished augmentation of airway hyperresponsiveness caused by OA inhalation.
CONCLUSION: Induction of apoptosis in proinflammatory cells including eosinophils at the airway may have a beneficial effect on suppressing airway hyperresponsiveness. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306985     DOI: 10.1159/000053727

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  5 in total

1.  Systemic FasL neutralization increases eosinophilic inflammation in a mouse model of asthma.

Authors:  S K Sharma; F A Almeida; S Kierstein; L Hortobagyi; T Lin; A Larkin; J Peterson; H Yagita; J G Zangrilli; A Haczku
Journal:  Allergy       Date:  2011-12-17       Impact factor: 13.146

2.  Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond.

Authors:  Amir A Zeki; Lisa Franzi; Jerold Last; Nicholas J Kenyon
Journal:  Am J Respir Crit Care Med       Date:  2009-07-16       Impact factor: 21.405

3.  MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets.

Authors:  Nancy Garbacki; Emmanuel Di Valentin; Vân Anh Huynh-Thu; Pierre Geurts; Alexandre Irrthum; Céline Crahay; Thierry Arnould; Christophe Deroanne; Jacques Piette; Didier Cataldo; Alain Colige
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

4.  Anti-Fas mAb-induced apoptosis and cytolysis of airway tissue eosinophils aggravates rather than resolves established inflammation.

Authors:  Lena Uller; Kristina Rydell-Törmänen; Carl G A Persson; Jonas S Erjefält
Journal:  Respir Res       Date:  2005-08-08

5.  Prevention of hyperoxia-induced bronchial hyperreactivity by sildenafil and vasoactive intestinal peptide: impact of preserved lung function and structure.

Authors:  Dorottya Czövek; Ferenc Peták; Yves Donati; Xavier Belin; Jean-Claude Pache; Constance Barazzone Argiroffo; Walid Habre
Journal:  Respir Res       Date:  2014-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.